
Share
The Finnish health tech company, known for its smart rings that track over 50 health metrics, is set to go public following a period of explosive growth and strong consumer demand.
Oura, the Finnish smart ring maker, has filed confidentially for an initial public offering (IPO) after reaching a valuation of $11 billion last year. The company submitted a draft registration statement with the Securities and Exchange Commission (SEC) on May 21. While the number of shares to be offered and the price range have not been determined, the IPO is expected to take place following the SEC's review process, subject to market conditions.
Founded in 2013, Oura has become a leader in wearable health technology. The company’s smart rings continuously track over 50 health metrics, including heart rate, sleep quality, daily movement, stress levels, fertility windows, and metabolic health. This comprehensive data collection has resonated with consumers, driving significant sales growth.
The company is on track to surpass five million paid members this quarter, a fourfold increase over the past two years. Last fall, Oura reported selling 5.5 million smart rings since 2015, with nearly 3 million of those sales occurring in 2025 alone. This strong demand has propelled Oura's revenue growth, with total revenue quadrupling over the past two fiscal years.
Oura CEO Tom Hale told CNBC that the company is expected to generate close to $2 billion in sales in 2026, a significant jump from the $1 billion in sales projected for 2025. The wearable brand has also invested its gross profit back into the business, fueling further innovation and expansion.
Customer retention remains a key strength for Oura, with 80% of members renewing their subscriptions after the first year. The company's smart rings are now available at over 4,600 retail locations globally and partner with more than 1,200 organizations across health, wellness, and commercial sectors.

"We’ve evolved beyond tracking to deliver actionable health intelligence that helps people better understand their bodies and make more informed decisions for their long-term health," Hale said in a recent statement. This focus on providing meaningful insights has been a driving force behind the company's success.
Oura's journey from a startup to a unicorn, now poised for an IPO, highlights the growing demand for wearable health technology. The market for wearables is expected to continue expanding, driven by increasing consumer awareness of personal health and wellness. According to a report by Grand View Research, the global smart wearable device market size was valued at $42.1 billion in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.7% from 2026 to 2033.
For investors, Oura's IPO presents an opportunity to participate in the growth of a company that has demonstrated strong financial performance and market traction. However, the competitive landscape of wearable technology is intense, with established players like Fitbit (now part of Google) and Apple continuing to innovate and capture significant market share.
The key risks for Oura include maintaining its technological edge, managing competition, and ensuring continued customer engagement. As the company transitions from a private to a public entity, it will also face increased scrutiny and pressure to meet investor expectations.
Oura's IPO is a significant milestone in the health tech industry, reflecting the growing consumer demand for wearable devices that provide actionable health insights. Investors should carefully consider the company's growth trajectory, competitive position, and market dynamics before making investment decisions.
Tags
Original Sources
Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
↗ https://www.fiercehealthcare.com/health-tech/oura-smart-ring-maker-files-confidentially-ipo-consumer-demand-propels-revenue-growth
About the author
Marcus began tracking AI's market implications in 2016, noticing AI-related patent filings accelerating ahead of earnings upgrades before most of the sell-side had caught on. A former fixed-income quantitative analyst, he spent two decades building models that priced risk across emerging markets before pivoting to cover the economic impact of AI full-time. His writing translates opaque technical developments into clear risk/reward terms — and he's rarely diplomatic about the gap between AI valuations and underlying fundamentals. He believes most market participants still underestimate AI's long-run deflationary effect on knowledge work.
More from The Analyst →This Week's Edition
3 June 2026
133 articles
Related Articles

Oura Files for IPO, Aiming to Capitalize on Growing Healthcare Wearables Market
Finance & Markets · 3 min

Swoop Expands Healthcare Reach with Nimble Acquisition, Targeting 16 Million Patients
Finance & Markets · 2 min

Garner Health Secures $100M Series E Funding, Reaching $2.74B Valuation
Finance & Markets · 3 min
Related Articles

Oura Files for IPO, Aiming to Capitalize on Growing Healthcare Wearables Market
Finance & Markets · 3 min

Swoop Expands Healthcare Reach with Nimble Acquisition, Targeting 16 Million Patients
Finance & Markets · 2 min

Garner Health Secures $100M Series E Funding, Reaching $2.74B Valuation
Finance & Markets · 3 min
More Stories